- Home
- CPOP vs APLT Comparison
CPOP vs APLT Comparison
Compare CPOP & APLT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | CPOP | APLT |
|---|---|---|
| Founded | 2007 | 2016 |
| Country | China | United States |
| Employees | N/A | N/A |
| Industry | Services-Misc. Amusement & Recreation | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 36.4M | 38.1M |
| IPO Year | 2021 | 2019 |
Fundamental Metrics
Financial Performance| Metric | CPOP | APLT |
|---|---|---|
| Price | $0.43 | $0.22 |
| Analyst Decision | | Hold |
| Analyst Count | 0 | 3 |
| Target Price | N/A | ★ $1.25 |
| AVG Volume (30 Days) | 729.1K | ★ 26.6M |
| Earning Date | 11-17-2025 | 11-13-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $107,632,769.00 | $1,000,000.00 |
| Revenue This Year | N/A | $124.18 |
| Revenue Next Year | N/A | $66.67 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 127.16 | N/A |
| 52 Week Low | $0.39 | $0.20 |
| 52 Week High | $2.61 | $1.50 |
Technical Indicators
Market Signals| Indicator | CPOP | APLT |
|---|---|---|
| Relative Strength Index (RSI) | 36.33 | 28.07 |
| Support Level | $0.40 | $0.20 |
| Resistance Level | $0.45 | $0.24 |
| Average True Range (ATR) | 0.06 | 0.04 |
| MACD | 0.01 | 0.01 |
| Stochastic Oscillator | 7.62 | 5.61 |
Price Performance
Historical ComparisonAbout CPOP Pop Culture Group Co. Ltd
Pop Culture Group Co Ltd hosts entertainment events, operates hip-hop-related online programs, and provides event planning and execution services and marketing services to corporate clients. It generates revenue from Event Hosting business by providing sponsorship packages to advertisers in exchange for sponsorship fees and by selling tickets for those concerts. The company has various operations services out of which Brand Promotion earns maximum revenue, following by Event Hosting, and Event Planning and Execution.
About APLT Applied Therapeutics Inc.
Applied Therapeutics Inc is a clinical-stage biopharmaceutical company, developing a pipeline of novel product candidates against validated molecular targets in indications of high unmet medical need. The company's drug compounds pipeline includes AT-007 which is a novel central nervous system, penetrant ARI that it is developing for the treatment of rare metabolic diseases, including Galactosemia and Sorbitol Dehydrogenase (SORD) Deficiency, AT-001 for the treatment of diabetic cardiomyopathy, and AT-003 for the treatment of diabetic retinopathy.